title: Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists.
authors.affiliation: Exploratory Chemistry Merck Sharp and Dohme Research Laboratories, Rahway, New Jersey 07065.
authors.forename: N B
authors.initials: NB
authors.lastname: Mantlo
authors.forename: P K
authors.initials: PK
authors.lastname: Chakravarty
authors.forename: D L
authors.initials: DL
authors.lastname: Ondeyka
authors.forename: P K
authors.initials: PK
authors.lastname: Siegl
authors.forename: R S
authors.initials: RS
authors.lastname: Chang
authors.forename: V J
authors.initials: VJ
authors.lastname: Lotti
authors.forename: K A
authors.initials: KA
authors.lastname: Faust
authors.forename: T B
authors.initials: TB
authors.lastname: Chen
authors.forename: T W
authors.initials: TW
authors.lastname: Schorn
authors.forename: C S
authors.initials: CS
authors.lastname: Sweet
mesh_terms: D000284:Administration, Oral; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000959:Antihypertensive Agents; D007093:Imidazoles / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology*; D051381:Rats; D013777:Tetrazoles / Q000494:pharmacology
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D007093:Imidazoles; D011687:Purines; D013777:Tetrazoles; C064191:1H-imidazo(4,5-b)pyridine; C070967:L 158809